A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of TBN

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of TBN	Nutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorder	Not yet recruiting	Phase 1	2026-09-11		NCT04667013

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Guangzhou Magpie Pharmaceuticals Co., Ltd.	2

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials